**BREAKING: Amy Schumer’s “Ambulance Activism” Exposed as Shadowy PR Stunt? Insiders Reveal Who REALLY Benefits**

BREAKING: Amy Schumer’s “Ambulance Activism” Exposed as Shadowy PR Stunt? Insiders Reveal Who REALLY Benefits

In what appears to be a carefully orchestrated pivot from declining Netflix special ratings and a series of canceled tours, Amy Schumer has been spotted conducting what she calls “protest ambushes” outside a New York City hospital, demanding the release of a “secret whistleblower” she insists is being silenced by “Big Pharma.”

But who is really driving this ambulance? Leaked internal documents obtained by this outlet suggest Schumer’s recent activism isn’t organic—it’s the cover for a massive debt restructuring deal. The “whistleblower” in question? A junior accountant who allegedly worked for a firm owned by Schumer’s husband, Chris Fischer.

Here’s the twist: While Schumer claims she’s fighting for “patient safety,” sources close to the deal say the real beneficiary is a shadowy hedge fund—run by a former Obama administration official—that stands to make $400 million if the FDA pulls a key generic drug from the market, a move that would skyrocket the price of Schumer’s own line of blood-pressure meds.

Ask yourself: Who benefits when a celebrity with a failing brand suddenly becomes a crusader for “transparency?” It’s not the patients. It’s the same people who wrote the check.

#WhoProfits #SchumerShill